# Effectiveness and Safety of Yisaipu Combined With Tripterygium Wilfordii for Active RA

> **NCT03589833** · PHASE4 · COMPLETED · sponsor: **Peking Union Medical College Hospital** · enrollment: 504 (actual)

## Conditions studied

- Arthritis, Rheumatoid

## Interventions

- **DRUG:** Tripterygium Wilfordii
- **DRUG:** Methotrexate
- **DRUG:** Yisaipu

## Key facts

- **NCT ID:** NCT03589833
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-14
- **Primary completion:** 2022-03-20
- **Final completion:** 2022-07-27
- **Target enrollment:** 504 (ACTUAL)
- **Last updated:** 2022-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03589833

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03589833, "Effectiveness and Safety of Yisaipu Combined With Tripterygium Wilfordii for Active RA". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03589833. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*